MergerLoop
  • Home
  • All Deals
  • Newsletter
  • 20 Weeks In Report
Back to register

MergerLoop is a DDLoop project

Back to register
WA-15033

Armira and TA Associates / Intersurgical Aktiengesellschaft AGWA-15033

View on ACCC

Processing timeline

25

days

Filed

25 July 2026

Notification waiver determination published

Decision

19 Aug 2026Notification waiver determination published
Type
Waiver
Outcome
Approved
Stage
Waiver application
Status
Assessment completed

Parties

Acquirer(s)

TA Riverside Aggregator, L.P., Armira Opportunities III GmbH & Co. geschlossene Investment KG

Target(s) or Vendor(s)

Intersurgical Aktiengesellschaft AG

Other parties

TA Investors 2024, L.P, TA Associates XV GP, L.P, TA XV-A, L.P, TA Associates Management, L.P., Armira GmbH & Co. KG HRA - 92168, Riverside BidCo Limited England and Wales Company Registration Number - 16880161, TA Associates XV EU GP, SARL, Riverside UK Holdco Limited England and Wales Company Registration Number - 16986637, Bock Capital EU Luxembourg Will S.à.r.l,, TA XV-B L.P, Riverside TopCo Limited Jersey Company Registration Number - 163852, Riverside Midco Limited England and Wales Company Registration - 16986520, TA Associates Cayman, LLC, TA XV-C, SCSp, Établissement Cosmeplast

Summary

Armira and TA Associates intend to indirectly acquire joint control of Intersurgical Aktiengesellschaft AG through a share purchase. This transaction involves a global designer, manufacturer, and supplier of medical devices for respiratory support, including for anaesthesia and intensive care.

Acquisition details

Armira Opportunities III GmbH & Co. geschlossene Investment KG ( Armira Opportunities III , and together with all affiliated companies and funds Armira ), and TA Riverside Aggregator LP ( TA Riverside Aggregator ), a special purpose vehicle created by certain funds controlled by TA Associates Cayman, LLC (the TA Funds , and together with all affiliated companies and funds, including TA Riverside Aggregator, TA Associates ) intend to indirectly acquire, through Riverside BidCo Limited ( Riverside BidCo ), joint control over the whole of Intersurgical Aktiengesellschaft AG ( Intersurgical , and together with all its controlled entities, the Intersurgical Group ) by way of purchase of shares (the Acquisition ). Armira is an alternative investment fund manager headquartered in Munich, Germany, which specialises in providing capital for long-term partnerships and focusing on family-owned businesses and technology companies, primarily in Europe. TA Associates is private equity firm headquartered in Boston, United States that invests, through the TA Funds, in companies across five target industries: technology, financial services, healthcare, consumer, and business services. Intersurgical is a Liechtenstein-based company which, through its operating subsidiaries (including Intersurgical Limited) controls the business of the Intersurgical Group. The Intersurgical Group is a global designer, manufacturer and supplier of medical devices for respiratory support, used in anaesthesia, intensive care, emergency care and oxygen therapy in hospitals and in the home. Its product range includes medical devices used in: Airway management Anaesthesia Emergency and resuscitation care Critical care Oxygen and aerosol therapy, nebuliser therapy, and respiratory physiotherapy.

Industry

Broad:Professional & Business Services

Decisions and key events

19 Aug 2026Notification waiver determination publishedAttachmentPDF129.2 KB

More Professional & Business Services deals

  • MUFG Pension & Market Services / Grow Technology ServicesMN-35030 · Notification · Filed 31 Aug 2026
  • Blackstone funds and Perpetual Trustees / HSBC loan portfolioMN-85047 · Notification · Filed 27 Aug 2026
  • WSP / e2mMN-35038 · Notification · Filed 26 Aug 2026
  • Herron Todd White / CJA Lee Property ValuersMN-75036 · Notification · Filed 25 Aug 2026
  • Novonesis / MicrobiogenMN-10030 · Notification · Filed 21 Aug 2026
  • Lone Star Funds / ContiTechMN-85043 · Notification · Filed 20 Aug 2026